Overview

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Status:
Not yet recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Bundang Hospital

Collaborator:

Daewon Pharmaceutical Co., Ltd.

Treatments:

Choline
Fenofibrate
Policosanol